Bonus BioGroup Ltd. (TLV:BONS)
Israel · Delayed Price · Currency is ILS · Price in ILA 20.40
-0.50 (-2.39%)
Aug 28, 2026, 1:44 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 241.8 million as of August 28, 2026. Its market cap has decreased by -16.85% in one year.
Market Cap
241.80M
Enterprise Value
249.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
20.40
ChartMarket Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 241.80M, an increase of 1,855.93%. That is a compound annual growth rate of 23.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 241.80M | -17.52% |
| Dec 31, 2025 | 293.15M | 110.92% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matricelf | 75.42M |
| BioLineRx | 39.31M |
| Clal Biotechnology Industries | 36.23M |
| BioLight Life Sciences | 29.93M |
| Evogene | 22.04M |
| Can-Fite BioPharma | 21.76M |
| XTL Biopharmaceuticals | 18.68M |
| Purple Biotech | 18.65M |